ERBB2 and cancer: In contrast to the results that associate morphine with cancer progression, Doornebal et al. showed in metastatic invasive lobular and HER2+ breast cancer mice models that doses of morphine used as analgesic did not affect mammary tumor growth, angiogenesis, and composition of immune cells in the presence or absence of surgery-induced tissue damage (62).